Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

di Inwards, D. J., Fishkin, P. A., LaPlant, B. R., Drake, M. T., Kurtin, P. J., Nikcevich, D. A., Wender, D. B., Lair, B. S., Witzig, T. E.
Pubblicato in Ann Oncol (2014)

Phase I trial of rituximab, cladribine, and temsirolimus (RCT) for initial therapy of mantle cell lymphoma

di Inwards, D J, Fishkin, P A, LaPlant, B R, Drake, M T, Kurtin, P J, Nikcevich, D A, Wender, D B, Lair, B S, Witzig, T E
Pubblicato in Ann Oncol (2019)

High rate of event-free survival at 24 months with everolimus/RCHOP for untreated diffuse large B-cell lymphoma: updated results from NCCTG N1085 (Alliance)

di Witzig, T E, LaPlant, B, Habermann, T M, McPhail, E, Inwards, D J, Micallef, I N, Colgan, J P, Nowakowski, G S, Ansell, S M, Johnston, P B
Pubblicato in Blood Cancer J (2017)

CD34(+) cell dose and establishment of full donor chimerism at day +100 are important factors for survival with reduced-intensity conditioning with fludarabine and melphalan before...

di Holtan, S G, Hogan, W J, Elliott, M A, Ansell, S M, Inwards, D J, Porrata, L F, Johnston, P B, Micallef, I N, Lacy, M Q, Gastineau, D A, Litzow, M R
Pubblicato in Bone Marrow Transplant (2010)

Widespread Use of Complementary and Alternative Medicine (CAM) among Non-Hodgkin Lymphoma (NHL) Survivors

di Osian, S. Rausch, Leal, A.D., Allmer, C., Maurer, M.J., Nowakowski, G., Inwards, D.J., Macon, W.R., Ehlers, S.L., Weiner, G.J., Habermann, T.M., Cerhan, J.R., Thompson, C.A.
Pubblicato in Leuk Lymphoma (2014)

Peripheral blood absolute lymphocyte/monocyte ratio recovery during ABVD treatment cycles predicts clinical outcomes in classical Hodgkin lymphoma

di Porrata, L F, Ristow, K M, Habermann, T M, Macon, W R, Witzig, T E, Colgan, J P, Inwards, D J, Ansell, S M, Micallef, I N, Johnston, P B, Nowakowski, G, Thompson, C A, Markovic, S N
Pubblicazione 2013

The role of front-line anthracycline-containing chemotherapy regimens in peripheral T-cell lymphomas

di Briski, R, Feldman, A L, Bailey, N G, Lim, M S, Ristow, K, Habermann, T M, Macon, W R, Inwards, D J, Colgan, J P, Nowakowski, G S, Kaminski, M S, Witzig, T E, Ansell, S M, Wilcox, R A
Pubblicazione 2014

Bowel perforation in intestinal lymphoma: incidence and clinical features

di Vaidya, R., Habermann, T. M., Donohue, J. H., Ristow, K. M., Maurer, M. J., Macon, W. R., Colgan, J. P., Inwards, D. J., Ansell, S. M., Porrata, L. F., Micallef, I. N., Johnston, P. B., Markovic, S. N., Thompson, C. A., Nowakowski, G. S., Witzig, T. E.
Pubblicazione 2013

Vitamin D insufficiency is associated with an increased risk of early clinical failure in follicular lymphoma

di Tracy, S I, Maurer, M J, Witzig, T E, Drake, M T, Ansell, S M, Nowakowski, G S, Thompson, C A, Inwards, D J, Johnston, P B, Micallef, I N, Allmer, C, Macon, W R, Weiner, G J, Slager, S L, Habermann, T M, Link, B K, Cerhan, J R
Pubblicato in Blood Cancer J (2017)

A Phase II Study of (153)Sm-EDTMP and High Dose Melphalan as a Peripheral Blood Stem Cell Conditioning Regimen in Patients with Multiple Myeloma

di Dispenzieri, A., Wiseman, G.A., Lacy, M.Q., Hayman, S.R., Kumar, S.K., Buadi, F., Dingli, D., Laumann, K.M., Allred, J., Geyer, S.M., Litzow, M.R., Gastineau, D.A., Inwards, D.J., Micallef, I.N., Ansell, S.M., Porrata, L., Elliott, M.A., Johnston, P.B., Hogan, W.J., Gertz, M.A.
Pubblicazione 2010